Correlation Between AN2 Therapeutics and Coya Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Coya Therapeutics, Common, you can compare the effects of market volatilities on AN2 Therapeutics and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Coya Therapeutics,.

Diversification Opportunities for AN2 Therapeutics and Coya Therapeutics,

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between AN2 and Coya is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and Coya Therapeutics,

Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the Coya Therapeutics,. In addition to that, AN2 Therapeutics is 1.47 times more volatile than Coya Therapeutics, Common. It trades about -0.01 of its total potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.03 per unit of volatility. If you would invest  457.00  in Coya Therapeutics, Common on September 14, 2024 and sell it today you would earn a total of  117.00  from holding Coya Therapeutics, Common or generate 25.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

AN2 Therapeutics  vs.  Coya Therapeutics, Common

 Performance 
       Timeline  
AN2 Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Coya Therapeutics, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coya Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Coya Therapeutics, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

AN2 Therapeutics and Coya Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AN2 Therapeutics and Coya Therapeutics,

The main advantage of trading using opposite AN2 Therapeutics and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.
The idea behind AN2 Therapeutics and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies